Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chengdu Qi Carbon Technology

Explore full profile

Fourth-generation nanopore gene sequencers and consumables manufacturer

Chengdu, ChinaFounded 2016Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2023
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Chengdu Qi Carbon Technology and the history behind them.

About Chengdu Qi Carbon Technology

Chengdu Qi Carbon Technology, also known as Qitan Tech, is a developer and manufacturer operating in the upstream segment of the gene sequencing industry. The company was established in September 2016 and is a collaborative effort by its founders, CEO Dr. Hu Geng, Dr. Xie Dan, and Chief Scientist Dr. Bai Jingwei. Dr. Bai, a Tsinghua University researcher, holds a Ph.D. in Materials Science from UCLA and has over a decade of experience in micro-nano device development, which is central to the company's technology.

The company's business model is centered on the research, development, manufacturing, and sale of nanopore gene sequencers, which represent the fourth generation of sequencing technology. This includes providing the core instruments as well as the accompanying proprietary consumables like sequencing chips (Qcells), reagents, and a one-stop data analysis platform. By supplying these foundational tools, Qitan Tech enables downstream clients to build out their own applications, positioning itself as a platform-level enterprise. Revenue is generated from the sale of these instruments and recurring sales of the necessary consumables. The company serves a diverse client base that includes hundreds of institutions such as disease control and prevention centers, hospitals, universities, and scientific research institutes.

Qitan Tech broke significant ground by developing China's first domestically-produced nanopore gene sequencer, addressing a critical dependency on foreign technology in the Chinese market. Its first commercial product, the QNome-3841, was launched in December 2021, marking the company's transition from R&D to commercialization. This instrument is a small-throughput sequencer noted for its portability and ability to deliver real-time results, making it suitable for applications that require rapid turnaround without the need to batch samples, such as in-field pathogen detection. Since then, the product line has expanded to include models like the QNome-3841hex and the portable, palm-sized QPursue-6k, which offers a medium throughput to support more data-intensive applications like large genome sequencing. The company has also established a production base in Chengdu's Tianfu International Bio-town, capable of annually producing 2,000 sequencers and one million sets of配套 chips and kits.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2016
Headquarters
Chengdu, China
Employees
7
Open positions
None listed
Dealroom signal
41.7/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Genetics and genomics, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Dec 2023 $14M $688M Chengdu High-tech Ceyuan Capital · Chengdu Bio-Town Investment ↗
SERIES COther financing Dec 2022 $96M $578M Alwin Capital · Meituan · Huagai Capital · BioTrack Capital ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Chengdu Qi Carbon Technology website traffic

Latest recorded traffic for Chengdu Qi Carbon Technology is 200 monthly website visits, down 41.2% over the last three months. Chengdu Qi Carbon Technology's team grew 16.7% over the past year.

Latest monthly visits200 3-month web change-41.2% 1-year team growth+16.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Empower Investment

Series A11 investors entered at this stage

Series B and later4 investors entered at this stage

  • Alwin Capital
  • Meituan
  • Chengdu High-tech Ceyuan Capital
  • Chengdu Bio-Town Investment
Employees 7 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chengdu Qi Carbon Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chengdu Qi Carbon Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.